Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTK6 | Q13882 | 11/20 | 0.47 |
| ▸ | LCK | P06239 | 2/20 | 0.36 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.36 |
| ▸ | SYK | P43405 | 1/20 | 0.36 |
| ▸ | PTK2 | Q05397 | 3/20 | 0.35 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.35 |
| ▸ | TTK | P33981 | 1/20 | 0.35 |
| ▸ | BRAF | P15056 | 1/20 | 0.35 |
| ▸ | MAPKAPK5 | Q8IW41 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30385212 | 0.95 | PTK6 (0.50) | PTK6LCKAURKBSYKPTK2 | |
| SCHEMBL30385303 | 0.90 | PTK6 (0.48) | PTK6LCKAURKBSYKTTK | |
| SCHEMBL22123969 | 0.90 | PTK6 (0.48) | PTK6LCKAURKBSYKTTK | |
| SCHEMBL22139113 | 0.88 | PTK6 (0.48) | PTK6LCKAURKBSYKMAPKAPK5 | |
| SCHEMBL30172107 | 0.88 | PTK6 (0.48) | PTK6LCKAURKBSYKMAPKAPK5 | |
| SCHEMBL25173403 | 0.86 | SYK (0.41) | PTK6AURKBSYKPTK2TTK | |
| SCHEMBL22125440 | 0.86 | PTK6 (0.59) | PTK6LCKAURKB | |
| SCHEMBL30171569 | 0.86 | PTK6 (0.59) | PTK6LCKAURKB | |
| SCHEMBL30384711 | 0.86 | PTK6 (0.47) | PTK6LCKAURKBSYKMAPKAPK5 | |
| SCHEMBL30386051 | 0.86 | PTK6 (0.40) | PTK6AURKBSYKPTK2TTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4161931-A1 | NOVEL IMIDAZOPYRAZINE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2023-04-12 | — | — | EP | disclosed |